The MU Health Care physician says unapproved 'research purposes' peptides lack the safety tracking Ozempic gets, and suggests asking a doctor before trying any.
Recap by typeshit. Full story at St. Louis Public Radio.
Dr Bajekal flags that people on Mounjaro, semaglutide or Wegovy should talk it through with their doctor ahead of an operation.
The Form 483 cites microbial growth in a clean hood, reversed cleanroom air pressure and active ingredients marked for research use only. Check which pharmacy filled your vial.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Citing the Wall Street Journal, Daily Mail Australia says personal injury firm Weitz and Luxenberg brought nearly all of the claims against the Wegovy and Ozempic maker.
Local news team runs a verify segment on retatrutide, the experimental weight-loss drug people are buying without approval.
Loading…